Clinical Trials

Inclusion Criteria:

• Diagnosis of obstructive sleep apnea obtained or confirmed within last 1 year with an in-lab polysomnography with Apnea Hypopnea Index ≥ 5 events/hour and < 30 events/hour.
• Poor tolerance or willingness to accept alternatives to the currently available standard Obstructive Sleep Apnea (OSA). OSA is a chronic disease and the most common form of Sleep-Disordered Breathing. It impairs quality of OSA treatments (CPAP and/or mandibular advancement device).
• Ownership for a smartphone capable of playing gamified Orofacial Myofunctional Therapy (OMT) protocol.
• Ability to follow on screen instructions while using gamified OMT protocol.

Exclusion Criteria:

• Significant co-morbid sleep disorders including excessive daytime sleepiness (Epworth sleepiness scale > 10), uncontrolled restless legs syndrome, insomnia
• Significant medical comorbidities including severe cardiopulmonary disease, chronic rhinosinusitis, neuromuscular disorder.
• Significant mental health comorbidities including history of uncontrolled anxiety, obsessive compulsive behavior and display of addictive behavior towards digital technology.
• Previous upper airway surgeries significantly modifying upper airway anatomy.
• Known congenital or acquired diseases significantly affecting upper airway anatomy.